Skip to main content
Log in

Management of pediatric migraine: Current concepts and controversies

  • Symposium on Neurological Disorders - Advances in Management
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Migraine in children and adolescents is a common condition. Emerging knowledge about the pathophysiology of migraine is leading to new targeted treatments toward specific mechanisms of migraine. This review explores the evidence for different treatments for pediatric migraine including the periodic syndromes of childhood that commonly represent precursors to migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abu-Arefeh, I, Russel G. Prevalence of headache and migraine in schoolchildren. Brit Med J 1994; 309: 765–769.

    PubMed  CAS  Google Scholar 

  2. Split W, Neuman W. Epidemiology of migraine among students from randomly selected secondary schools in Lodz. Headache 1999; 39: 494–501.

    Article  PubMed  CAS  Google Scholar 

  3. Oleson J. The international classification of headache disorders. Cephalalgia 2004; 24: 1–160

    Google Scholar 

  4. Hershey AD, Winner P, Kabbouche MA, Gladstein J, Yonker M, Lewis D et al. Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache 2005; 45: 1288–1297.

    PubMed  Google Scholar 

  5. Rossi LN, Vajani S, Cortinovis I, Spreafico F, Menegazzo L. Analysis of the International Classification of Headache Disorders for diagnosis of migraine and tension-type headache in children. Developmental Medicine and Child Neurology. 2008;50: 305–310

    Article  PubMed  Google Scholar 

  6. Winner P. Pediatric Headache. Current Opinion in Neurology 2008; 21:316–322.

    Article  PubMed  Google Scholar 

  7. Virtanen R, Aromaa M, Rautava P, Metsähonkala L, Anttila P, Helenius H et al. Changing headache from preschool age to puberty. Cephalalgia 2007; 27: 294–303.

    Article  PubMed  CAS  Google Scholar 

  8. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 2007; 13: 39–44.

    Article  PubMed  CAS  Google Scholar 

  9. Pietrobon, D, Striessnig J. Neurobiology of migraine. Nature Reviews 2003; 4: 386–398.

    Article  PubMed  CAS  Google Scholar 

  10. Silberstein S. Migraine. Lancet 2004;31: 381–391.

    Article  CAS  Google Scholar 

  11. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Annals of Neurology 2004; 55:19–26.

    Article  PubMed  CAS  Google Scholar 

  12. Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, Darcel F, Vicaut E, Bousser MG, Tournier-Lasserve E. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. New England 2001; 345: 17–24.

    Article  CAS  Google Scholar 

  13. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nature Genetics 2003; 33: 192–196.

    Article  PubMed  CAS  Google Scholar 

  14. Vanmolkot KR, Kors EE, Hottenga JJ, Terwindt GM, Haan J, Hoefnagels WA et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003; 54: 360–366.

    Article  PubMed  CAS  Google Scholar 

  15. Kabbouche MA, Powers SW, Vockell AL, LeCates SL, Ellinor PL, Segers A et al. Outcome of a multidisciplinary approach to pediatric migraine at 1, 2, and 5 years. Headache 2005; 45: 1298–1303.

    PubMed  Google Scholar 

  16. Damen L, Bruijn J, Koes BW, Berger MY, Passchier J, Verhagen AP. Prophylactic treatment of migraine in children. Part 1. A systematic review of non-pharmacologic trials. Cephalagia 2005; 26: 373–383.

    Article  Google Scholar 

  17. Bruni O, Russo PM, Ferri R, Novelli L, Galli F, Guidetti V. Relationships between headache and sleep in a non-clinical population of children and adolescents. Sleep Medicine 2008; 9: 542–548.

    Article  PubMed  CAS  Google Scholar 

  18. Heng K, Wirrell E. Sleep disturbance in children with migraine. Child Neurology 2006; 21:761–766.

    Article  Google Scholar 

  19. Lewis DW, Yonker M, Winner P, Sowell M. The treatment of pediatric migraine. Pediatric Annals 2005; 34: 449–460

    Google Scholar 

  20. Powers SW, Andrasik F. Biobehavioural treatment, disability and psychological effects of pediatric headache. Pediatric Annals 2005; 34: 461–465.

    PubMed  Google Scholar 

  21. Powers SW, Hershey AD. Biofeedback for childhood migraine. In Maria BL, ed. Current Management in Child Neurology, 2nd ed. Hamilton, Ontario: BC Decker Inc; 2002; 83–85.

    Google Scholar 

  22. Eccleston C, Yorke L, Morley S, William AC de C, Mastroyannopoulou K. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Systems Review 2003; 1: 1–46

    Google Scholar 

  23. Kohen DP, Zajac R. Self-hypnosis training for headaches in children and adolescents. J Pediatr 2007; 150: 635–639.

    Article  PubMed  Google Scholar 

  24. Burstein R, Collin B. An association between migraine and cutaneous allodynia. Annals of Neurology 2000; 47: 614–624

    Article  PubMed  CAS  Google Scholar 

  25. Eidlitz-Markus T, Shuper A, Gorali O, Zeharia A. Migraine and cephalic cutaneous allodynia in pediatric patients. Headache 2007; 47: 1219–1223.

    Article  PubMed  Google Scholar 

  26. Lewis DW, Winner P, Wasiewski W. The placebo responder rate in children and adolescents. Headache 2005; 45: 232–239.

    Article  PubMed  Google Scholar 

  27. Fernandes R, Ferreira JJ, Sampaio C. The placebo response in studies of acute migraine. J Pediatr 2008; 152: 527–533.

    Article  PubMed  Google Scholar 

  28. Hamalainen ML, Hoppu K, Velkeila E Santavuori P. Ibuprofen or acetaminopen for the acute treatment of migraine in children: a double-blinded, randomized, placebo-controled crossover study. Neurology 1997; 48: 103–107.

    Article  PubMed  CAS  Google Scholar 

  29. Lewis DW, Kellstein D, Dahl G, Burke B, Frank LM, Toors, Northam RS, White LW, Lawson L. Children’s ibuprofen suspension for the acute treatment of pediatric migraine. Headache 2002; 42: 780–786.

    Article  PubMed  Google Scholar 

  30. Lewis DW, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the AAN quality standards subcommittee and the Practice Committee of the Child Neurology Society 2004; 63: 2215–2224.

    CAS  Google Scholar 

  31. Dodick DW. Triptan nonresponder studies: Implications for clinical practice. Headache 2005; 45: 156–162.

    Article  PubMed  Google Scholar 

  32. Rapoport AM, Tepper SJ. Triptans are all different. Archives of Neurology 2001; 58: 1479–1480.

    Article  PubMed  CAS  Google Scholar 

  33. Dahlöf C. Infrequent or non-response to oral sumatriptan does not predict response to other triptans - review of four trials. Cephalalgia 2006; 26: 98–106.

    Article  PubMed  Google Scholar 

  34. Winner P, Rothner AD, Saper K et al. A randomized doubleblind, placebo controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000; 106: 989–997.

    Article  PubMed  CAS  Google Scholar 

  35. Ahohen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in the treatment of migraine attacks in children. Neurology 2004; 62: 883–887.

    Google Scholar 

  36. Lewis DW, Winner P, Hershey AD, Wasiewski WW. Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007;120: 390–396.

    Article  PubMed  Google Scholar 

  37. Ahonen K, Hamalainen ML, Eerola M, Hoppu K. A randomized trial of rizatriptan in migraine attacks in children. Neurology 2006; 67: 1135–1140.

    Article  PubMed  CAS  Google Scholar 

  38. Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW. Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial. Headache 2008 (epub ahead of print)

  39. Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ et al. Rapoport AM; MK-0974 Protocol 004 study group. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008; 70: 1304–1312.

    Article  PubMed  CAS  Google Scholar 

  40. Aurora S, Kori S, Barrodale P, Nelsen A, McDonald S. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache 2007; 47: 1443–1446

    Article  PubMed  Google Scholar 

  41. Aurora SK, Kori SH, Barrodale P, McDonald SA, Haseley D. Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache 2006; 46: 57–63.

    Article  PubMed  Google Scholar 

  42. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Annals of Emergency Medicine 2004; 43: 256–262.

    Article  PubMed  Google Scholar 

  43. Sorge F, Marano E. Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia 1985;5 Suppl 2:145–148.

    PubMed  Google Scholar 

  44. Sorge F, De Simone R, Marano E, Nolano M, Orefice G, Carrieri P. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 1988; 8: 1–6.

    Article  PubMed  CAS  Google Scholar 

  45. Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000; 40: 539–549.

    Article  PubMed  CAS  Google Scholar 

  46. Lewis DW, Winner P. The Pharmacological Treatment Options for Pediatric Migraine: An Evidence-Based Appraisal. NeuroRx 2006; 3: 181–191.

    Article  PubMed  CAS  Google Scholar 

  47. Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 2004; 44: 230–237.

    Article  PubMed  Google Scholar 

  48. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005; 45: 1304–1312.

    PubMed  Google Scholar 

  49. Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebocontrolled trial. Child Neurology 2007; 22: 829–835.

    Article  CAS  Google Scholar 

  50. Lewis DW, Paradiso E. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study. Headache 2007; 47: 1409–1417.

    PubMed  Google Scholar 

  51. Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 2000; 40: 672–676.

    Article  PubMed  CAS  Google Scholar 

  52. Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M. Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study. Headache 2008; 48: 1012–1025.

    Article  PubMed  Google Scholar 

  53. Pakalnis A, Kring D, Meier L. Levetiracetam prophylaxis in pediatric migraine-an open-label study. Headache 2007; 47: 427–430.

    PubMed  Google Scholar 

  54. Lindskog U, Odkvist L, Noaksson L, Wallquist J. Benign paroxysmal vertigo in childhood: a long-term follow-up. Headache 1999; 39: 33–37.

    Article  PubMed  CAS  Google Scholar 

  55. Lewis DW. Headaches in Children and Adolescents. Current Problems in Pediatric and Adolescent Health Care 2007; 37: 207–246.

    Article  PubMed  Google Scholar 

  56. Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 2006; 130: 1527–1537.

    Article  Google Scholar 

  57. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams J, Staiano A, Staiano A, Walker S. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006; 130:1527–1537.

    Article  PubMed  Google Scholar 

  58. Abu-Arafeh I, Russel G. Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Archives of Diseases of Childhood 1995; 72: 413–417.

    Article  CAS  Google Scholar 

  59. Li BUK, Murray RD, Heitlinger LA, Robbins JL, Hayes JR. Is cyclic vomiting syndrome related to migraine? J Pediatr 1999; 134:567–572.

    Article  PubMed  CAS  Google Scholar 

  60. Li BUK, Balint JP. Cyclic vomiting syndrome: evolution in our understanding of a brain-gut disorder. Advances in Pediatrics 2000; 47: 117–160.

    PubMed  CAS  Google Scholar 

  61. Al-Tawaijri WA, Shevell MI. Pediatric migraine equivalents: occurrence and clinical features in practice. Pediatr Neurol 2002; 26: 365–368.

    Article  Google Scholar 

  62. Fleisher DR. Cyclic Vomiting Syndrome: a paroxysmal disorder of brain -gut interaction. J Pediatr Gastroenterol and Nutr 1997; 25: 13S–15S.

    Article  Google Scholar 

  63. Tarbell S, Li BU. Psychiatric symptoms in children and adolescents with cyclic vomiting syndrome and their parents. Headache 2008; 48: 259–266.

    PubMed  Google Scholar 

  64. Fitzpatrick E, Bourke B, Drumm B, Rowland M. Outcome for children with cyclic vomiting syndrome. Archives of Diseases of Childhood 2007; 92: 1001–1004.

    Article  CAS  Google Scholar 

  65. Lindley K, Andrews P. Pathogenesis and Treatment of Cyclic Vomiting. J Pediatric Gastroenterol and Nutr 2005; 41: S38–S40.

    Article  Google Scholar 

  66. Fleisher DR. Empiric guidelines for the management of cyclical vomiting syndrome. www.ch.missouri.edu/fleisher 2008.

  67. Kothare SV. Efficacy of flunarizine in the prophylaxis of cyclical vomiting syndrome and abdominal migraine. European J Pediatric Neurol 2005; 9: 23–26.

    Article  Google Scholar 

  68. Andersen JM, Sugerman KS, Lockhart JR, Weinberg WA. Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics 1997; 100: 977–981.

    Article  PubMed  CAS  Google Scholar 

  69. Weydert JA, Ball TM, Davis MF. Systematic review of treatments for recurrent abdominal pain. Pediatrics 2003; 111: e11.

    Article  Google Scholar 

  70. Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Archives of Disease in Childhood 1995; 72: 48–50.

    Article  PubMed  CAS  Google Scholar 

  71. Worawattanakul M, Rhoads JM, Lichtman SN, Ulshen MH. Abdominal migraine: prophylactic treatment and followup. J Pediatric Gastroenterol and Nutr 1999;28:37–40.

    Article  CAS  Google Scholar 

  72. Boccia G, Del Giudice E, Crisanti AF, Strisciuglio C, Romano A, Staiano A. Functional gastrointestinal disorders in migrainous children: efficacy of flunarizine. Cephalalgia 2006; 26: 1214–1219.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daune L. MacGregor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hung, R.M., MacGregor, D.L. Management of pediatric migraine: Current concepts and controversies. Indian J Pediatr 75, 1139–1148 (2008). https://doi.org/10.1007/S12098-008-0238-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/S12098-008-0238-8

Key words

Navigation